Advisory Board Resolution on the subject: «Possibilities of personalized hormone-based therapies for endometriosis using dydrogesterone / Approval of the protocol of an Observational Open-Label Multicenter Study of Real Clinical Practice to Evaluate the Effects of Hormonal therapy with Oral Dydrogesterone for Treatment of Confirmed Endometriosis (the ORCHIDEA study)»

doi:https://doi.org/10.17116/repro20182405141

Journal: Russian Journal of Human Reproduction. 2018;24(5): 41‑44

DOI: 10.17116/repro20182405141

Read: 4089 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)

Использование инфографики авторами научных работ

References:

Ginekologiya: nacional’noe rukovodstvo. Pod red. GM Savel’evoj, GT Suhih, VN Serova, IB Manuhina, VE Radzinskogo. 2-e izd., pererab. i dopoln. M.: GEHOTAR-Media; 2017. (In Russ.)
Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, Heikinheimo O, Horne AW, Kiesel L, Nap A, Prentice A, Saridogan E, Soriano D, Nelen W; European Society of Human Reproduction and Embryology. ESHRE guideline: management of women with endometriosis. Human Reproduction. 2014;29(3):400-412. https://doi.org/10.1093/humrep/det457
Ehndometrioz. Klinicheskie rekomendacii. 2016. Accessed June 11, 2018. (In Russ.) Available at: http://cr.rosminzdrav.ru/#!/recomend/182
Liang B, Wu L, Xu H, Cheung CW, Fung WY, Wong SW, Wang CC. Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice. Reproductive Biology and Endocrinology. 2018;16(1):32. https://doi.org/10.1186/s12958-018-0347-9
Vercellini P, Buggio L, Berlanda N, Barbara G, Somigliana E, Bosari S. Estrogen-progestins and progestins for the management of endometriosis. Fertility and Sterility. 2016;106(7):1552-1571. https://doi.org/10.1016/j.fertnstert.2016.10.022
Vercellini P, Buggio L, Frattaruolo MP, Borghi A, Dridi M, Somigliana E. Medical treatment of endometriosis-related pain. Best Practice and Research Clinical Obstetrics and Gynaecology. 2018;51:68-91. https://doi.org/10.1016/j.bpobgyn.2018.01.015
Pallacks C, Hirchenhain J, Krüssel JS, Fehm TN, Fehr D. Endometriosis doubles odds for miscarriage in patients undergoing IVF or ICSI. European Journal of Obstetric, Gynecology, and Reproductive Biology. 2017;213:33-38. https://doi.org/10.1016/j.ejogrb.2017.04.008
Prikaz Ministerstva zdravoohraneniya Rossijskoj Federacii №572n ot 01.11.12 «Ob utverzhdenii Poryadka okazaniya medicinskoj pomoshchi po profilyu «akusherstvo i ginekologiya» (za isklyucheniem ispol’zovaniya vspomogatel’nyh reproduktivnyh tekhnologij». Accessed 1.June, 2018. (In Russ.) Available at: https://www.rosminzdrav.ru/documents
Gosudarstvennyj reestr lekarstvennyh sredstv. Accessed June 11, 2018. (In Russ.) Available at: https://grls.rosminzdrav.ru
Schweppe KW. The place of dydrogesterone in the treatment of endometriosis and adenomyosis. Maturitas. 2009;65(Suppl 1):S23-S27. https://doi.org/10.1016/j.maturitas.2009.11.011
Trivedi P, Selvaraj K, Mahapatra PD, Srivastava S, Malik S. Effective post-laparoscopic treatment of endometriosis with dydrogesterone. Gynecological Endocrinology. 2007;23(Suppl 1):73-76.
Dubrovina SA, Berlim Yu.D. Gestagens in the treatment of endometriosis. Akusherstvo i ginekologiya. 2018;5:150-155. (In Russ.) https://doi.org/10.18565/aig.2018.5.150-155
Instrukciya po medicinskomu primeneniyu preparata Dyufaston ot 26.02.2018. Accessed June 11, 2018. (In Russ.) Available at: https://medi.ru/instrukciya/dyufaston_2881/
Santulli P, Marcellin L, Menard S, Thubert T, Khoshnood B, Gayet V, Goffinet F, Ancel PY, Chapron C. Increased rate of spontaneous miscarriages in endometriosis-affected women. Human Reproduction. 2016;31(5):1014-1023. https://doi.org/10.1093/humrep/dew035
Nickkho-Amiry M, Savant R, Majumder K, Edi-O’sagie E, Akhtar M. The effect of surgical management of endometrioma on the IVF/ICSI outcomes when compared with no treatment? A systematic review and meta-analysis. Archives of Gynecology and Obstetrics. 2018;297(4):1043-1057. https://doi.org/10.1007/s00404-017-4640-1
Carp HJA. Progestogens and pregnancy loss. Climacteric. 2018;21(4):380-384. https://doi.org/10.1080/13697137.2018.1436166
Recurrent pregnancy loss. Guideline of the European Society of Human Reproduction and Embryology (ESHRE). Accessed June 11, 2018. Available at: https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Recurrent-pregnancy-loss.aspx
Toth B, Würfel W, Bohlmann M, Zschocke J, Rudnik-Schöneborn S, Nawroth F, Schleußner E, Rogenhofer N, Wischmann T, von Wolff M, Hancke K, von Otte S, Kuon R, Feil K, Tempfer C. Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/050). Geburtshilfe und Frauenheilkunde. 2018;78(4):364-381. https://doi.org/10.1055/a-0586-4568
Podzolkova NM, Tatarchuk T.F., Doshanova AM, Eshimbetova GZ, Sumyatina lV Correction of menstrual cycle with dydrogesterone. Akusherstvo i ginekologiya. 2018;6:70-76. (In Russ.) https://doi.org/10.18565/aig.2018.6
McKenzie LJ. Surgical Management of Endometriosis Associated Infertility: Time for a Paradigm Change. Contemporary Obstetrics and Gynecology. 2015;60(4):7-10.
Informaciya o deyatel’nosti farmpredpriyatiya Abbott Laboratories. Accessed June 11, 2018. (In Russ.) Available at: http://tass.ru/ekonomika/5111905
Tournaye H, Sukhikh GT, Kahler E, Griesinger G. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Human Reproduction. 2017;32(5):1019-1027. https://doi.org/10.1093/humrep/dex023